At a glance
This program funds collaborative projects that develop, demonstrate, and spread innovative solutions to speed translational research across the CTSA Program and beyond. Eligible applicants include CTSA Program hubs and CTSA partnering institutions, and applications must fit the research interests of at least one participating NIH Institute, Center, or Office. The announcement does not state the number or size of awards or any cost-share requirement. Some topics have special scope limits, including NHGRI support for genomics tools for clinical trials, NIAID support for preclinical chemical countermeasure research only, and NIH institute-specific interests such as FDA regulatory science, NCATS data science and clinical trial innovation, and NIAMS disease-related translation.
What it funds
Official description from grants.gov
The CTSA Collaborative and Innovative Acceleration Award (CCIA) aims to accelerate the pace of translational research by supporting the collaborative development, dissemination, and sustainable implementation of innovative solutions across the CTSA Program Consortium and beyond. This Notice of Funding Opportunity (NOFO) invites investigator-initiated applications to develop, demonstrate, and disseminate innovative new approaches, technologies, resources, or models that increase the impact of research across diseases, transform the field of translational science, and bring more treatments for all people more quickly.
Who can apply
- Public and State controlled institutions of higher education